Synapse - Works

Results (601)

A prospective study of allogeneic stem cell transplantation of A/B T-lymphocyte depleted graft conditioned with a reduced intensity regimen in patients with hematologic malignancies

Meeting Abstract

Tamari, R.; Flynn, J.; Shaffer, B.; Jakubowski, A.; Papadopoulos, E.; Devlin, S.; Lin, R.; Giralt, S.; Perales, M. A.
Bone Marrow Transplantation (2023)

Fulltext@MSK | Save

Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma

Meeting Abstract

Nishimura, N.; Brown, S.; Sean, M. D.; Parastoo, D.; Heather, J. L.; Oscar, B. L.; Michael, S.; Gunjan, L. S.; David, J. C.; Hani, H.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation

Journal Article

Elias, S.; Brown, S.; Devlin, S. M.; Barker, J. N.; Cho, C.; Chung, D. J.; Dahi, P. B.; Giralt, S.; Gyurkocza, B.; Jakubowski, A. A.; more...
British Journal of Haematology (2023)

Fulltext@MSK | Save

18F-FDG PET/CT features as potent imaging biomarkers of efficacy and toxicity in large-B-cell lymphoma treated with CAR-T cell therapy

Meeting Abstract

Leithner, D.; Flynn, J. R.; Mauguen, A.; Devlin, S. M.; Fei, T.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; Lafontaine, D.; Michaud, L.; more...
European Journal of Nuclear Medicine and Molecular Imaging (2023)

Fulltext@MSK | Save

Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias

Meeting Abstract

Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)

Meeting Abstract

Nishimura, N.; Flynn, J.; Costa, B.; Devlin, S.; Farzana, T.; Nath, K.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Vitamin D deficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma

Meeting Abstract

Nishimura, N.; Flynn, J.; Costa, B.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; Shah, G.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Prognostic impact of corticosteroid and tocilizumab use on the efficacy of chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma

Meeting Abstract

Costa, B.; Flynn, J.; Nath, K.; Nishimura, N.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia

Journal Article

Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
American Journal of Hematology (2023)

Fulltext@MSK | Save

Vemurafenib and obinutuzumab as frontline therapy for hairy cell leukemia

Journal Article

Park, J. H.; Devlin, S.; Durham, B. H.; Winer, E. S.; Huntington, S.; von Keudell, G.; Vemuri, S.; Shukla, M.; Falco, V.; Cuello, B.; more...
NEJM Evidence (2023)

Fulltext@MSK | Save